Target intelligence / Profile preview

RNA, U6 small nuclear 669, pseudogene (RNU6-669P)

Target
RNU6-669P
Molecular classification
Other (pseudogene), Non-coding RNA
01

Overview

RNU6-669P (RNA, U6 small nuclear 669, pseudogene) is annotated as a human pseudogene homologous to U6 small nuclear RNA, but it does not produce functional RNA and is not considered a receptor, enzyme, transporter, or typical molecular target. The U6 small nuclear RNA (snRNA) itself is essential for the catalytic function of the spliceosome and is highly conserved in eukaryotes, with many genomic copies and pseudogenes[1][3]. Pseudogenes such as RNU6-669P may arise from duplication or retrotransposition events and typically lack promoter activity, are not translated, and do not fulfill canonical snRNA function. Some pseudogenes in general can regulate gene expression by acting as decoys for miRNA or RNA-binding proteins, or by generating non-coding RNAs, but there is no published evidence linking RNU6-669P to therapeutically relevant roles or disease biology[2]. There are no drugs, biomarkers, or molecular mechanisms attributed to this pseudogene, and it is not considered a therapeutic target. Key facts: - The canonical, functional molecule is U6 snRNA, a core noncoding RNA involved in mRNA splicing[1][3]. - "Pseudogene" designation (RNU6-669P) means it does not produce functional protein or RNA and should not be considered a target. - U6 snRNA pseudogenes (including RNU6-669P) are abundant in the human genome but not known to be of clinical or drug relevance[3]. - Entry is incorrect as a target: it is not a receptor, enzyme, transporter, or therapeutic target.

Other names
RNU6-669PU6 snRNA pseudogene 669RNA, U6 small nuclear RNA pseudogene 669
02

Biological functions

Pseudogenes generally lack direct biological functions, but may potentially act as miRNA decoys, endogenous siRNA sources, or influence parental gene regulation through competitive binding or epigenetic modulation[2].For U6 snRNA pseudogenes specifically, standard annotation does not associate functional roles, as they do not encode active snRNA.
03

Disease associations

Other (no validated disease association)Some pseudogenes can be aberrantly expressed in cancer and other diseases[2], but no specific evidence is reported for RNU6-669P.

Beyond the preview

Go deeper on RNA, U6 small nuclear 669, pseudogene (RNU6-669P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 669, pseudogene (RNU6-669P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call